Home » Stocks » Wave Life Sciences

Wave Life Sciences Ltd. (WVE)

Stock Price: $9.39 USD -0.04 (-0.42%)
Updated Aug 11, 2020 2:36 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 335.53M
Revenue (ttm) 17.12M
Net Income (ttm) -196.93M
Shares Out 35.73M
EPS (ttm) -5.74
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 11, 2020
Last Price $9.39
Previous Close $9.43
Change ($) -0.04
Change (%) -0.42%
Day's Open 9.50
Day's Range 9.26 - 9.50
Day's Volume 195,244
52-Week Range 6.61 - 39.98

More Stats

Market Cap 335.53M
Enterprise Value 246.36M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 35.73M
Float 4.73M
EPS (basic) -5.74
EPS (diluted) -5.74
FCF / Share -4.88
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.20M
Short Ratio 14.06
Short % of Float 20.47%
Beta -0.09
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 19.60
PB Ratio 15.38
Revenue 17.12M
Operating Income -210.32M
Net Income -196.93M
Free Cash Flow -168.09M
Net Cash 89.17M
Net Cash / Share 2.50
Gross Margin -931.46%
Operating Margin -1,228.66%
Profit Margin -1,150.40%
FCF Margin -981.95%
ROA -38.65%
ROE -168.71%
ROIC -484.30%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (7)

Buy 4
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$16.50*
(75.72% upside)
Low
8.00
Current: $9.39
High
21.00
Target: 16.50
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013
Revenue15.9814.413.891.090.15--
Revenue Growth10.89%270.25%256.5%618.42%---
Gross Profit15.9814.413.891.090.15--
Operating Income-208-160-102-55.72-19.30-5.39-3.57
Net Income-194-147-102-55.66-19.20-5.23-3.32
Shares Outstanding33.8728.9726.5122.8010.503.911.74
Earnings Per Share-5.72-5.06-3.85-2.44-1.83-1.34-1.90
Operating Cash Flow-188-22.86-83.67-31.93-12.53-4.43-3.55
Capital Expenditures-3.92-9.94-18.89-5.56-1.86-0.58-0.05
Free Cash Flow-192-32.80-103-37.49-14.38-5.00-3.60
Cash & Equivalents1471751431501621.050.00
Total Debt32.55-0.020.080.14--
Net Cash / Debt1151751421501621.050.00
Assets2842961821651652.94-
Liabilities21321534.3622.074.060.91-
Book Value63.7373.351401351532.03-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Wave Life Sciences Ltd.
Country Singapore
Employees 301
CEO Paul B. Bolno

Stock Information

Ticker Symbol WVE
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: WVE
IPO Date November 11, 2015

Description

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.